1. Background {#sec64773}
=============

*Streptococcus pneumoniae* is a common etiological agent of serious invasive infections and the most common cause of pneumonia, which is a major cause of mortality throughout the world ([@A12714R1], [@A12714R2]). On the verge of the antibiotic era, clinical isolates of *S. pneumoniae* showed a high sensitivity to antibiotics such as benzylpenicillin, which had an exceptionally low (5-10 ng/mL) Minimum Inhibitory Concentration (MIC) against these strains. Penicillin has been commonly recommended as the antibiotic for pneumococcal infections. The emergence of drug-resistant *S. pneumoniae* posed a new difficult challenge for treatment of these infections ([@A12714R3]). The initial incidence of clinically important penicillin-resistant isolates has since been reported worldwide.

The spread of penicillin and multidrug resistance among *S. pneumonia* has become an important universal issue and a challenge for the present treatment strategies ([@A12714R4]). β-lactams are the most widely used antibiotics; however, extensive resistance has evolved among most common pathogens such as *S. pneumoniae* ([@A12714R5], [@A12714R6]). Antimicrobial susceptibility records on common pathogens including *Escherichia coli, Klebsiella spp., Haemophilus influenzae, Staphylococcus aureus, S. pneumoniae,*and*S. pyogenes* confirmed that antimicrobial resistance is still a limited issue ([@A12714R7]). Penicillin and macrolide resistance in *S. pneumoniae* are considered as a serious concern globally, particularly, in Asian countries ([@A12714R8]). The β-lactam antibiotics are broadly utilized to treat community and healthcare-associated infections, and the appearance and spread of antimicrobial resistance to this family of drugs is a significant threat to human health ([@A12714R9]).

Several resistance mechanisms have been reported, including expression of drug-destroying enzymes such as β-lactamases ([@A12714R10], [@A12714R11]), altered drug targets such as conformational changes in *PBPs* ([@A12714R10]), decreased bacterial permeability ([@A12714R10]), and increased drug efflux ([@A12714R12]). Understanding the principles for resistance mechanisms is essential and important for surveillance and control of infections. Furthermore, appropriate antimicrobial use is also of importance, for instance penicillins and cephalosporins (members of B-lactam antibiotics) inhibit *PBPs,* which are vital for bacterial cell wall biogenesis. Pathogenic bacteria have developed efficient antibiotic resistance mechanisms which in gram-positive bacteria, includes mutations in *PBP* genes that facilitate avoidance of B-lactam inhibition ([@A12714R13]).

Resistance of *S. pneumoniae* to β -lactams is due to reduced affinity of PBPs, particularly *PBP1A*, *PBP2B* and *PBP2X*. *S. pneumoniae* contains the mosaic pbp sequence, which has high homology with pbp in oral streptococci ([@A12714R14]). Resistance of *S. pneumoniae* to Β-lactams results from homologous recombination of *pbp* with the *pbp* genes of β-lactam-resistant oral streptococci ([@A12714R15]-[@A12714R19]). Thus, molecular epidemiological analysis, antimicrobial susceptibilities and resistance genes analysis are crucial in prevention and therapy of infectious diseases such as drug resistance in *S. pneumoniae*. Therefore, clinical laboratories should consider screening selected isolates to determine their susceptibility to macrolides, β-lactams, vancomycin or clindamycin.

2. Objectives {#sec64774}
=============

This study aimed to investigate the true prevalence of β-lactam resistance among clinically important isolates of *S. pneumoniae* and to examine susceptibility of *S. pneumoniae* to various antimicrobial agents including benzylpenicillin, imipenem, oxacillin and ceftazidim. In addition, the distribution of *PBP* genes of *pbp1a*, *pbp2b*, and *pbp2x* was investigated. Furthermore, the changes in MIC and dispensation of the antimicrobial-resistance genes were compared.

3. Materials and Methods {#sec64779}
========================

3.1. Bacterial Strains {#sec64775}
----------------------

Isolates of *S. pneumoniae* (n = 55) were collected from outpatients seen at the Medical Center of Hamadan. Clinical samples were cerebro-spinal fluid (CSF) ([@A12714R6]), sputum ([@A12714R20]), otorrhea ([@A12714R1]), pharynx ([@A12714R8]) and others ([@A12714R2]).

3.2. Identification of Bacterial Isolates {#sec64776}
-----------------------------------------

All isolates were identified according to the method summarized by the Centers for Disease Control ([@A12714R21]). Gram-positive cocci α- hemolytic colonies on blood agar plates supplemented with 5 mg/ mL gentamycin were collected with a wire loop and subcultured on blood agar plates. An optochin disk with a diameter of 6 mm (5 mg ethylhydrocupreine) was placed aseptically on the streak of inoculum. The plate was incubated at 37˚C in a 5% CO~2~ atmosphere for 18-24 hours. Isolates with an inhibition zone of 14 mm in diameter, which were susceptible to optochin, were selected. Strains with inhibition zones ranging from 9 mm to 13 mm were tested for bile solubility using 2% sodium deoxycholate (bile salt) (Oxoid, Basingstoke, Hamsphire, England). Finally isolates were confirmed by polymerase chain reaction (PCR) for autolysin (*lytA*) gene ([@A12714R22]-[@A12714R24]). Isolates were stored in 15% glycerol at -80˚ C until used for PCR and E-Test ([@A12714R25], [@A12714R26]).

3.3. Antimicrobial Test {#sec64777}
-----------------------

The drug susceptibility of confirmed samples with microbial tests was determined using antibiotic E-test strips (Himedia Laboratories pvt. Ltd, India). Antibiotics employed in this study were: benzylpenicillin, imipenem, oxacillin, and ceftazidim. Inocula were prepared by direct suspension of colonies grown overnight on sheep blood agar in Muller-Hinton broth to achieve turbidity equivalent to a 0.5 Mc-Farland opacity standard. The 100-mm-diameter agar plates were inoculated by confluent swabbing of the surface with the adjusted inoculum suspensions. After application of the E-test strips, pneumococcal test plates were incubated in ambient air at 35˚C for 20 to 22 hours ([@A12714R25]-[@A12714R28]). E-test MICs were interpreted by noting the point of intersection of the growth ellipse margin with the MIC scale on the E-test strip when viewed from the upper agar surface with the plate lids removed ([Figure 1](#fig12664){ref-type="fig"}).

![Antibiogram Procedure by E-test\
a, sensitive; b, resistant.](jjm-07-12714-g001){#fig12664}

3.4. Polymerase Chain Reaction Analysis {#sec64778}
---------------------------------------

Isolates were grown in blood agar medium containing 5% sheep blood agar (Merck, Darmstadt, Germany) with 5% CO~2~ at 37˚C for 48 hours. A single colony of *S. pneumoniae* was removed and suspended in lysis solution as reported previously and cells were lysed for 10 minutes at 60˚C followed by 5 minutes at 94˚C ([@A12714R22], [@A12714R28]). Furthermore, 1 µL of supernatant was used for the PCR reaction. Each reaction tube contained 20 µL solutions that included 10 x buffer (2 µL), MgCl~2~ 25 Mm (0.4 µL), dNTPs 10 Mm (0.8 µL), distilled water (13.7 µL), Taq 5 U/µL (0.2 µL), DNA (1 µL), primer 1 (10 pm) (1 µL) and primer 2 (10 pm) (1 µL). Amplification of *pbp1a*, *pbp2b*, and *pbp2x* were examined by PCR using the primers reported by Ubukata and co-workers ([@A12714R22], [@A12714R29]). To raise the percentage of PRSP strains and to compensate for the variety of gene mutations, primers were designed to amplify the genes of susceptible strains but not of resistant strains.

Primer pairs used included: for *lytA*, 5\'-TGAAGCGGATTATCATGGC-3\' and 3\'-GCTAAACTCCCT GTATCAAGCG-5\' (273bp); for *pbp1A*, 5\'-AAACAA GGTCGGACTCAACC-3\' and 5-\'AGGTGCTACAAATTGAGAGG-3\' (430 bp); for *Pbp2X*, 5\'-CCAGGTTCC ACTATGAAAGTG-3\' and 5\'-CATCCGTCAAACC GAAACGG-3\' (292bp); for *Pbp2B*, 5\'-CAATCTAGAGTC TGCTATGGA- 3\' and 5-\'GGTCAATTCCTGTCGC AGTA-3\' (77 bp). PCR conditions were as follows: initial denaturation step at 94˚C for 3 minutes followed by 30 cycles at 94˚C for 20 seconds , 57˚C for 20 seconds and 72˚C for 15 seconds, and a final extension step at 72˚C for 7 minutes ([@A12714R21]). The amplified DNA fragments were separated on a 3% agarose gel. *S. pneumoniae* PTCC 1240 was used as the control strain.

4. Results {#sec64780}
==========

Fifty five out of 400 samples were positive for *S. pneumoniae* with microbial test and PCR ([Figure 2](#fig12665){ref-type="fig"}).

![Polymerase Chain Reaction for Identification of *lytA* Gene (273 bp) in Isolates\
Gel electrophoresis with autolysin gene (L = marker 50 bp, agarose LE 3%, A = negative control with distilled water, B = negative control with *E. coli*, C = positive control with *S. pneumoniae* (PTCC NO.1240), D-J = *lytA* gene (273bp))](jjm-07-12714-g002){#fig12665}

All 55 strains were classified into following six genotypes, according to PCR for pbp1a, pbp2x, pbp2b genes:

i.  PSSP with three normal genes (n = 0%);

ii. PISP with abnormal *pbp2x* (n = 100%);

iii. PISP with abnormal *pbp2b* (n = 100%);

iv. PISP with abnormal *pbp1a* (n = 85.5%);

v.  PISP (*pbp2x*+2b) with abnormal *pbp2x* and *pbp2b* (n = 100%);

vi. PISP (*pbp1a*+2x) with abnormal *pbp1a* and *pbp2x* (n = 100%);

vii. PISP (*pbp1a*+2b) with abnormal *pbp1a* and *pbp2b* (n = 100%);

viii. PRSP with three abnormal PBP genes (n = 85.5%). E-test results revealed that 94.5% of isolates were resistant to penicillin, 100% to oxacillin, 100% to imipenem, and 21.8% to ceftazidime.

The most frequent genotype of penicillin resistance genes were related to pbp2x and pbp2b. Furthermore, 85.5 % of the samples with PRSP genotype had all three mutant genes and none of the samples were sensitive to penicillin. All samples had at least two genes related to penicillin resistance. Samples with one or two penicillin resistance genes had intermediate resistance to penicillin. [Figure 3](#fig12666){ref-type="fig"} indicates the relationship between distributions of antimicrobial minimum inhibitory concentrations for *S. pneumoniae* in mutations of PBP genes.

![Antimicrobial Minimum Inhibitory Concentrations for *Streptococcus pneumoniae* in *PBP* Genes Mutants](jjm-07-12714-i001){#fig12666}

The highest percentage of antibiotic resistance was towards oxacillin and imipenem (100%). In addition, 94.5 % of samples were resistant to penicillin, imipenem and oxacillin, while 21% of samples were resistant to all tested antibiotic E-test strips. The most frequent penicillin resistance genes were *pbp2x* and *pbp2b* while 85.5 % of the samples had the PRSP genotype (had all three mutated genes). Furthermore, no penicillin sensitive strain was detected and 100% of the samples had at least two penicillin resistance genes and those with one or two penicillin resistance genes had intermediate penicillin resistance (PISP).

5. Discussion {#sec64781}
=============

Pneumococci have remained as important human pathogens despite the introduction of penicillin and the new generation of antibiotics. Our results showed that the incidence of penicillin-resistant strains among Iranian clinical isolates is alarmingly high. The rate of resistance to penicillin in our isolates was higher than the resistance rates reported from other countries, underlining the necessity for more attention to be paid to antibiotic therapy for pneumococcal infections. A detailed study from Brazil indicated that the prevalence of resistant strains increased during the six years of the study period according to analysis of MICs ([@A12714R30]).

The present study showed a 94.5% prevalence rate for penicillin resistant *S. pneumoniae*. This is higher than the 67.8% reported from Tanzania ([@A12714R31]) and 64% from Kuwait ([@A12714R32]) and very higher than the 9.5% reported from Zahedan, Iran ([@A12714R33]). PCR is a rapid and simple technique with high sensitivity and specificity for detection of microorganisms ([@A12714R34]-[@A12714R37]). Primarily, a microbial test and PCR were conducted to determine *S. pneumoniae*. PCR analysis confirmed the microbial test results. Since the first cases of invasive pneumococcal infections caused by PRSP were reported in 1977, penicillin-nonsusceptible strains have become a global concern ([@A12714R38]). Several reports have determined a high prevalence of pneumococcal resistance to penicillin as well as other antibiotics, such as cephalosporins and macrolides.

A recent survey in the United States showed that 18.4% of isolates were resistant to penicillin ([@A12714R20]). Furthermore, the overall proportion of the isolates which were resistant to three or more classes of drugs was reported to be increased ([@A12714R39]). Some studies have documented the emergence of decreased susceptibility of *S. pneumoniae* to fluoroquinolones; in addition, a failure in therapy of cases with pneumococcal pneumonia treated with oral levofloxacin has been reported ([@A12714R40], [@A12714R41]). A number of factors have been reported to play a role in carriage and transmission of penicillin resistant. *S. pneumonia*; however, the most important factor is probably recent antibiotic use. Other risk factors for resistant pneumococcal carriage include young age, attendance to day care centers, and human immunodeficiency virus (HIV) infections in some populations ([@A12714R42], [@A12714R43]).

Autolysins are enzymes that degrade different bonds in the peptidoglycan which ultimately result in the lysis and death of the cell. The *S. pneumoniae* contains a powerful autolytic enzyme that has been described as an N-acetylmuramoyl-L-alanine amidase ([@A12714R44], [@A12714R45]). The autolysin *LytA* is responsible for release of lipoteichoic and teichoic acids, which are host inflammatory response mediators. Neuraminidase ([@A12714R45]) is a choline-binding protein which is found in the cytoplasm of *S. pneumoniae* and released when the cells undergo autolysis. Cell wall autolysin may have a function in pathogenesis of *S. pneumoniae* through lysing a proportion of the invading pneumococci, which causes the release of potentially lethal toxins. Earlier studies have revealed that autolysin releases extremely inflammatory cell wall breakdown products, which eventually contribute to pathogenesis ([@A12714R44], [@A12714R45]). In addition, autolysin-deficient *S. pneumoniae* were shown to have a degree of attenuated virulence in one of the previous reports ([@A12714R44]). Therefore, it can be presumed that autolysin contributes to early pathogenesis of the pneumococcal disease.

In the present study, all of our isolates were positive for *lytA,* irrespective of the kind of disease they were causing. All the isolates from both invasive and ocular infections were *lytA* positive suggesting that irrespective of site of isolation and kind of infection, autolysin is a necessity for the *S. pneumoniae* isolates. In the current work, examination of MICs for β-lactams, including penicillin, imipenem, oxacillin, ceftazidim, showed a trend in *S. pneumoniae* resistance to β-lactams. The existence of mutant *PBP* genes affected the MIC of β-lactam resistance since the occurrence of these genes in resistant was higher compared to the sensitive isolates ([Figure 3](#fig12666){ref-type="fig"}).

The lower affinity of *PBPs*, 1A, 2B and 2X are involved in β-lactams-resistance in *S. pneumoniae*. Furthermore, we used PCR with primers specific to susceptible alleles for the detection of mutations in *PBP* genes, which demonstrated that 85% of isolates had mutations in the *PBP* genes. The comparison of these results with results of E-test demonstrated that there are other *PBP* genes, which are involved in low frequency of resistance. Previous studies have shown strong associations between the use of antimicrobial agents in the community and emergence of antimicrobial resistance in a number of organisms ([@A12714R46], [@A12714R47]). This might be due to selection of the resistant strains which have mutations in the *PBP* genes that result from β-lactam utilization. Another possibility is the implantation of transformation between *S. pneumoniae* and related streptococcal species. The increase in β-lactam resistant *S. pneumoniae* might be associated with the increase in highly resistant strains and rapid transfer of cloned resistance which in turn could be due to introduction and administration of new β-lactam and macrolide antibiotics as well as high population and travel to affected areas.

A number of strategies including simultaneous multiple drug therapy, which have been reported to be effective in reducing the development of resistance in pathogens such as HIV and mycobacterium tuberculosis are not practical for *S. pneumoniae* due to within-host development of resistance during treatment ([@A12714R48]). In the United States and Europe, decreased resistance by judicious antibiotic use has been reported ([@A12714R48]). However, this strategy is not practical in for developing country such as Iran where antibiotics are sold without prescription over the counter. The present results suggest that it is important to appraise the changes in MIC values as well as genetic mutations in order to evaluate the prevalence of resistance to antimicrobial agents in *S. pneumoniae*. Furthermore, penicillin is not suitable for treatment of pneumococcal infections; instead a range of macrolides can be administrated to successfully treat strains with intermediate resistance to penicillin in serious infections. However, the necessity of using macrolides should be considered due to the increased macrolides resistance in this family.

For strains with high resistance to penicillin, vancomycin and fluoroquinolones including sparfloxacin are selected as antimicrobial agents. In addition, selected antibiotics should be administrated to treat pneumococcal bacterial infection based on the pattern of pneumococcal drug resistance in the area. Thus, in isolates assumed to be *S. pneumoniae*, examination of three PBP and lytA together gives value to predict the susceptibility within two hours which finally leads to a selective treatment for infectious diseases caused by *S. pneumonia* ([@A12714R37]). Consequently, the increase in antibiotic resistance among *S. pneumoniae* strains in Iran seems to be alerting and the treatment of infections should be further analyzed and investigated and thus presently antibiotics used for practical treatment of certain *S. pneumoniae* infections may need to be further reviewed.
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